Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,707 | -3,667 | -4,794 |
| Depreciation Amortization | 732 | 215 | 261 |
| Accounts receivable | -1,496 | -1,222 | -166 |
| Accounts payable and accrued liabilities | 465 | 329 | -237 |
| Other Working Capital | 73 | -718 | 19 |
| Other Operating Activity | 2,282 | 1,189 | 357 |
| Operating Cash Flow | $-2,652 | $-3,873 | $-4,560 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -545 | -204 | -30 |
| Purchase Of Investment | -30,954 | N/A | N/A |
| Sale Of Investment | 2,794 | N/A | N/A |
| Investing Cash Flow | $-28,706 | $-204 | $-30 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 3,000 | N/A |
| Debt Repayment | -3,000 | -7 | -40 |
| Common Stock Issued | 24,118 | 6 | 12 |
| Other Financing Activity | 10,553 | 0 | 1,924 |
| Financing Cash Flow | $31,671 | $2,999 | $1,895 |
| Beginning Cash Position | 1,623 | 2,701 | 5,396 |
| End Cash Position | 1,936 | 1,623 | 2,701 |
| Net Cash Flow | $314 | $-1,078 | $-2,695 |
| Free Cash Flow | |||
| Operating Cash Flow | -2,652 | -3,873 | -4,560 |
| Capital Expenditure | -545 | -204 | -30 |
| Free Cash Flow | -3,197 | -4,077 | -4,590 |